CASEY LYNCH

Profile

First Name

: CASEY

Middle Name

:

Last Name

: LYNCH

Related Companies
Titles
Company Name
Related People
EXECUTIVE OFFICER, DIRECTOR
MCLARENS YOUNG INTERNATIONAL LTD
EUGENE BECKER, GARY C. BROWN, VERNON F. CHALFANT, GARY K. GABRIEL, JESSE ROGERS, KEONI SCHWARTZ
EXECUTIVE OFFICER
ACP INVESTMENT FUND II, L.P.
RANDALL EASON, JESSE ROGERS, KEONI SCHWARTZ
EXECUTIVE OFFICER
ACP INVESTMENT FUND II-A, L.P.
RANDALL EASON, JESSE ROGERS, KEONI SCHWARTZ
EXECUTIVE OFFICER, DIRECTOR
CORTEXYME, INC.
LUCA BENATTI, JUNE BRAY, STEPHEN DOMINY, STEPHEN A. DOMINY, KRISTEN GAFRIC, BRENDAN HANNAH, DAVID LAMOND, MARGI MCLOUGHLIN, RAJIV PATNI, ROGER QUY, BRIGETTE ROBERTS, CHARLES RYAN, UNA RYAN, CHRISTOPHER SENNER, DIRK THYE, ILAN ZIPKIN
EXECUTIVE OFFICER
ACP INVESTMENT FUND III-A, L.P.
RANDALL EASON, JESSE ROGERS, KEONI SCHWARTZ
EXECUTIVE OFFICER
ACP PRIVATE INVESTORS III, L.P.
RANDALL EASON, JESSE ROGERS, KEONI SCHWARTZ
EXECUTIVE OFFICER
ACP INVESTMENT FUND III, L.P.
RANDALL EASON, JESSE ROGERS, KEONI SCHWARTZ
EXECUTIVE OFFICER
ACP PRIVATE INVESTORS III-A, L.P.
RANDALL EASON, JESSE ROGERS, KEONI SCHWARTZ
DIRECTOR
UNDISPUTED BOXING, INC.
REBECCA BRAGG, ALEX GOULD, BRIAN SCHWARTZ, MICHAEL SPECTOR
EXECUTIVE OFFICER, DIRECTOR
SYFS INTERMEDIATE HOLDINGS, LLC
CHUCK FARKAS, MELISSA FRANCIS, JASON FRIEDRICHS, JERRY RHODES, JOHN RIPLEY, JOHN STUPAK
EXECUTIVE OFFICER
MW COTTONWOOD INVESTORS, LLC
ROUNDHOUSE ADVISORS, LLC
EXECUTIVE OFFICER
MW ASHLYN PLACE HOLDINGS, LLC
DAVID BUCK, ROUNDHOUSE ADVISORS, LLC
EXECUTIVE OFFICER
MW CW RIVER, LLC
DAVID BUCK, ROUNDHOUSE ADVISORS, LLC
EXECUTIVE OFFICER, PROMOTER
ROUNDHOUSE MULTIFAMILY FUND II LP
DAVID BUCK, KATIE VILA
EXECUTIVE OFFICER, PROMOTER
RMF2 SILVERBROOK CO-INVEST LP
DAVID BUCK, KATIE VILA
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
LIGHTHOUSE PHARMACEUTICALS, INC.
STEPHEN DOMINY, CAMPBELL MURRAY
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2026-05-07
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2026-04-22 
2026-04-02
D/A
Link
PRIVATE EQUITY FUND 
 
DECLINE TO DISCLOSE 
Equity 
2025-04-09 
2026-04-02
D/A
Link
PRIVATE EQUITY FUND 
 
DECLINE TO DISCLOSE 
Equity 
2025-04-03 
2022-03-16
D
Link
COMMERCIAL 
 
DECLINE TO DISCLOSE 
Equity 
2022-02-24 
2021-12-16
D
Link
COMMERCIAL 
 
DECLINE TO DISCLOSE 
Equity 
2021-12-01 
2020-12-16
D
Link
COMMERCIAL 
 
DECLINE TO DISCLOSE 
Equity 
2020-12-10 
2020-05-04
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2020-04-21 
2018-05-31
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2018-05-23 
2017-11-07
D/A
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2017-05-02 
2017-09-14
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
 
2017-09-01 
2017-05-16
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2017-05-02 
2017-03-15
D
Link
PRIVATE EQUITY FUND 
 
DECLINE TO DISCLOSE 
 
2017-03-03 
2017-02-14
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2017-02-01 
2016-12-14
D
Link
PRIVATE EQUITY FUND 
 
DECLINE TO DISCLOSE 
 
2016-12-01 
2016-12-14
D
Link
PRIVATE EQUITY FUND 
 
DECLINE TO DISCLOSE 
 
2016-12-01 
2016-12-14
D
Link
PRIVATE EQUITY FUND 
 
DECLINE TO DISCLOSE 
 
2016-12-01 
2016-01-05
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2015-12-22 
2013-12-23
D
Link
PRIVATE EQUITY FUND 
 
DECLINE TO DISCLOSE 
 
2013-12-12 
2013-12-23
D
Link
PRIVATE EQUITY FUND 
 
DECLINE TO DISCLOSE 
 
2013-12-12 
2011-09-27
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2011-09-13